Graf Akcie APEN (Apollo Endosurgery Inc). Diskuze k akciím APEN. Aktuální informace APEN.

Základní informace o společnosti Apollo Endosurgery Inc (Akcie APEN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 262.63M
Hodnota podniku (EV) N/A
Tržby 56.153M
EBITDA N/A
Zisk -13.72
Růst v tržbách Q/Q 194.29 %
Růst v tržbách Y/Y 41.76 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.17
EV/Sales 5.12
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 4.13
P/FCF N/A
Price/Book 34.36
Účetní hodnota na akcii 0.24
Hotovost na akcii 1.35
FCF vůči ceně -6.29 %
Počet zaměstnanců 158
Tržba na zaměstnance 355.399k
Profit margin -53.77 %
Operating margin -18.39 %
Gross margin 52.90 %
EBIT margin -14.46 %
EBITDA margin -60.86 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -63.33 %
EPS - Očekávaný růst příští rok 172.73 %
Return on assets -17.91 %
Return on equity -243.14 %
ROIC -22.65 %
ROCE -13.54 %
Dluhy/Equity 10.47
Čistý dluh/EBITDA -4.26
Current ratio 3.95
Quick Ratio 3.20
Volatilita 7.70
Beta 0.60
RSI 40.00
Cílová cena analytiků 5
Známka akcie (dle analytiků) N/A
Insider ownership 20.47 %
Institutional ownership 53.60 %
Počet akcií 28.703M
Procento shortovaných akcií 2.19 %
Short ratio 2.66 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie APEN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$50.713$60.854$64.31$64.65$67.79$5.081
Cost Of Goods Sold$25.038$27.66$24.578$25.255$20.51-
Gross Profit$25.675$33.194$39.732$39.395$47.28$5.081
Research And Development Expenses$10.384$12.176$8.299$7.805$9.558$18.127
SG&A Expenses$42.318$46.267$46.632$45.158$47.579$4.759
Other Operating Income Or Expenses$5.609$-7.77----
Operating Expenses$74.226$100.947$86.749$85.411$84.473$22.886
Operating Income$-23.513$-40.093$-22.439$-20.761$-16.683$-17.805
Total Non-Operating Income/Expense$-3.644$-5.503$-4.549$-20.019$-10.699$1.25
Pre-Tax Income$-27.157$-45.596$-26.988$-40.78$-27.382$-16.555
Income Taxes$0.275$0.191$0.304$0.387$0.049-
Income After Taxes$-27.432$-45.787$-27.292$-41.167$-27.431$-16.555
Other Income------
Income From Continuous Operations$-27.432$-45.787$-27.292$-41.167$-27.431$-16.555
Income From Discontinued Operations------
Net Income$-27.432$-45.787$-27.292$-41.167$-36.382$-16.555
EBITDA$-18.833$-30.31$-12.423$-11.244$-7.737$-17.589
EBIT$-23.513$-40.093$-22.439$-20.761$-16.683$-17.805
Basic Shares Outstanding222014000
Shares Outstanding222014000
Basic EPS$-1.27$-2.31$-2.01$-105.69$-151.90$-77.04
EPS - Earnings Per Share$-1.27$-2.31$-2.01$-105.69$-151.90$-77.04
# 2020 2019 2018 2017 2016 2015
Current Ratio0.96611.96832.23022.15092.21024.3285
Long-term Debt / Capital0.89730.42360.40030.48170.8621-
Debt/Equity Ratio24.96610.7350.66760.92956.2497-
Gross Margin50.62854.54761.78260.935869.7448100
Operating Margin-46.3648-65.8839-34.8919-32.1129-24.6098-350.4615
EBIT Margin-46.3648-65.8839-34.8919-32.1129-24.6098-350.4615
EBITDA Margin-37.1364-49.8077-19.3174-17.3921-11.4132-346.2083
Pre-Tax Profit Margin-53.5504-74.9269-41.9655-63.0781-40.3924-325.8572
Net Profit Margin-54.0926-75.2407-42.4382-63.6767-53.6687-325.8572
Asset Turnover0.680.81720.58970.63310.64450.2424
Inventory Turnover Ratio2.82442.78491.71362.07641.6032-
Receiveable Turnover5.49325.34235.4836.15196.45746.9865
Days Sales In Receivables66.446168.322866.569559.331656.524152.2433
ROE - Return On Equity-1292.136-158.8172-54.6792-97.053120.5064-104.67
Return On Tangible Equity249.4272-334.6758-409.544532.837372.1831-121.9119
ROA - Return On Assets-36.781-61.4855-25.0245-40.3108-26.0781-78.9909
ROI - Return On Investment-132.6691-91.5374-32.7895-50.2994-33.8771-104.67
Book Value Per Share0.10131.31642.88663.968314.773863.3797
Operating Cash Flow Per Share-0.0212-0.186332.097633.6083.9784.7115
Free Cash Flow Per Share0.0409-0.169634.618250.8179-15.37634.476